Cargando…

Sample Preparation of Posaconazole Oral Suspensions for Identification of the Crystal Form of the Active Pharmaceutical Ingredient

Determination of the polymorphic form of an active pharmaceutical ingredient (API) in a suspension could be really challenging because of the water phase and the low concentration of the API in this formulation. Posaconazole is an antifungal drug available also as an oral suspension. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lykouras, Michail, Fertaki, Stefani, Orkoula, Malvina, Kontoyannis, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766814/ https://www.ncbi.nlm.nih.gov/pubmed/33352808 http://dx.doi.org/10.3390/molecules25246032

Ejemplares similares

Formation and Characterisation of Posaconazole Hydrate Form
por: Lykouras, Michail, et al.
Publicado: (2022)

Warfarin Sodium Stability in Oral Formulations
por: Dimitrokalli, Evangelia, et al.
Publicado: (2021)

Measuring Bismuth Oxide Particle Size and Morphology in Film-Coated Tablets
por: Fertaki, Stefani, et al.
Publicado: (2022)

Comparative Study of Sample Carriers for the Identification of Volatile Compounds in Biological Fluids Using Raman Spectroscopy
por: Papaspyridakou, Panagiota, et al.
Publicado: (2022)

Combining Raman Microspectroscopy and X-ray Microcomputed Tomography for the Study of Bone Quality in Apolipoprotein-Deficient Animal Models
por: Fertaki, Stefani, et al.
Publicado: (2023)

FT-IR/ATR Solid Film Formation: Qualitative and Quantitative Analysis of a Piperacillin-Tazobactam Formulation
por: Chrisikou, Ioanna, et al.
Publicado: (2020)

Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam
por: Chrisikou, Ioanna, et al.
Publicado: (2021)

Effect of Plant Extracts on the Characteristics of Silver Nanoparticles for Topical Application
por: Siakavella, Ioanna K., et al.
Publicado: (2020)

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
por: Belling, Morgan, et al.
Publicado: (2017)

1469 Posaconazole salvage treatment for invasive fungal infection : a single center experience with utilization of posaconazole oral suspension or delayed-released tablet
por: Kim, Jong Hun, et al.
Publicado: (2014)

Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
por: Suh, Hyeon Jeong, et al.
Publicado: (2017)

The Impact of Gelatin on the Pharmaceutical Characteristics of Fucoidan Microspheres with Posaconazole
por: Szekalska, Marta, et al.
Publicado: (2021)

A Comparative Study of Newly Developed HPLC-DAD and UHPLC-UV Assays for the Determination of Posaconazole in Bulk Powder and Suspension Dosage Form
por: Hamdy, Dalia A., et al.
Publicado: (2014)

Clinical Outcomes of the Oral Suspension vs Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
por: Tallman, Gregory B, et al.
Publicado: (2017)

Safety, Tolerability, and Pharmacokinetics (PK) of Posaconazole (POS) Intravenous (IV) Solution and Oral Powder for Suspension in Children With Neutropenia
por: Groll, Andreas H, et al.
Publicado: (2017)

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
por: Arrieta, Antonio C., et al.
Publicado: (2019)

Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
por: Furuno, Jon P., et al.
Publicado: (2018)

Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
por: Ye, Peipei, et al.
Publicado: (2022)

Mechanochemical Preparation of Active Pharmaceutical Ingredients Monitored by In Situ Raman Spectroscopy
por: Sović, Irena, et al.
Publicado: (2020)

The Impact of Hypromellose on Pharmaceutical Properties of Alginate Microparticles as Novel Drug Carriers for Posaconazole
por: Kruk, Katarzyna, et al.
Publicado: (2023)

Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase
por: Chasapis, Christos T., et al.
Publicado: (2010)

1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia
por: Winchell, Gregory A, et al.
Publicado: (2019)

Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient—Mexiletine Hydrochloride
por: Andrews, Jessica L., et al.
Publicado: (2022)

Recovery of Active Pharmaceutical Ingredients from Unused Solid Dosage-Form Drugs
por: Pratama, Dhanang Edy, et al.
Publicado: (2020)

The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients
por: Janczura, Magdalena, et al.
Publicado: (2022)

Non-Destructive and Non-Invasive Measurement of Ethanol and Toxic Alcohol Strengths in Beverages and Spirits Using Portable Raman Spectroscopy
por: Papaspyridakou, Panagiota, et al.
Publicado: (2023)

Posaconazole for lobomycosis
por: Pasqualotto, Alessandro C., et al.
Publicado: (2021)

Chemical Engineering in the Pharmaceutical Industry, Active Pharmaceutical Ingredients
por: Ende, David
Publicado: (2019)

Co-Crystals: A Novel Approach to Modify Physicochemical Properties of Active Pharmaceutical Ingredients
por: Yadav, A. V., et al.
Publicado: (2009)

Raman Spectroscopy for the Quantitative Analysis of Solid Dosage Forms of the Active Pharmaceutical Ingredient of Febuxostat
por: Rimsha, Gull, et al.
Publicado: (2023)

Optimized Suspension Trapping Method for Phosphoproteomics Sample Preparation
por: Wang, Fujia, et al.
Publicado: (2023)

Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies
por: Leclerc, Elisabeth, et al.
Publicado: (2018)

Spherical crystallization: A technique use to reform solubility and flow property of active pharmaceutical ingredients
por: Chatterjee, Arindam, et al.
Publicado: (2017)

Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients
por: Watson, Oliver L., et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Microbatch under-oil salt screening of organic cations: single-crystal growth of active pharmaceutical ingredients
por: Babor, Martin, et al.
Publicado: (2019)

Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
por: Stocker, Michael W., et al.
Publicado: (2022)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
por: De Groot, Anne S., et al.
Publicado: (2013)

Structure of the active pharmaceutical ingredient bismuth subsalicylate
por: Svensson Grape, Erik, et al.
Publicado: (2022)

Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients
por: Cores, Ángel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_due9fihmi5u95voev9spigmfgg